The researchers will determine whether this higher dose of dialysis will change rates of hospitalization and improve blood pressure, blood counts, diet or quality of life. G. John Chen, M.D., Ph. D., assistant professor of public health sciences-social sciences and health policy, will assist in developing an economic analysis of the costs of the two different forms of dialysis.
John M. Burkart, M.D., professor of medicine-nephrology, will direct the portion of the study at Wake Forest Baptist, which will involve 13 dialysis centers: in Winston-Salem, High Point, Lexington, Thomasville, Mt. Airy, King, Elkin, Statesville and Lake Norman.
The other clinical centers include Lynchburg Nephrology in Lynchburg, Va; Rubin Dialysis Center in Saratoga Springs, N.Y.; The Dialysis Clinic in Kansas City, Mo; Rogosin Institute in New York City; University of Western Ontario in London, Ontario, Canada; Indiana University in Indianapolis, Ind.; Washington University St. Louis in St. Louis, Mo; the University of Iowa in Iowa City, Iowa, and Metabolic Associates in New Haven, Conn.
The study is scheduled to begin accepting patients in the fall of 2004.
'"/>
Contact: Robert Conn
rconn@wfubmc.edu
336-716-4587
Wake Forest University Baptist Medical Center
9-Mar-2004